Companies /Healthcare

Biogen Inc

NASDAQ: BIIB Drug Manufacturers - General
$219.88
▼ $2.94 (−1.32%) today
Markets closed · 8:31pm ET

24/7 Wall St. View

Fundamentals

Market Cap
$32.5B
P/E Ratio
39.6
Profit Margin
8.3%
Revenue (TTM)
$10.0B
EPS (TTM)
$5.56
52-Week Range
$138 – $230
Street Target
$238.18

About Biogen

Biogen Inc. is a pioneer in the biotechnology sector, focusing on developing treatments for neurological and neurodegenerative conditions. With a global presence, Biogen offers a range of therapies for diseases such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's. Its portfolio includes well-known drugs like TECFIDERA, SPINRAZA, and ADUHELM. Additionally, Biogen is involved in creating biosimilars, which are essentially generic versions of biologic drugs, expanding its impact on healthcare. Founded in 1978 and based in Cambridge, Massachusetts, Biogen continues to push the boundaries of medicine through innovation and partnerships.

Latest Activity

  • ADBEAdobe Inc. - Common Stock (ADBE)Partial sell$15K – $50KAug 14
  • ALCHern Family Foundation Alcon Inc. Ordinary Shares (ALC)Sell$1K – $15KAug 5
  • BUDKevin Hern Traditional IRA Anheuser-Busch Inbev SA Sponsored ADR (BUD)Sell$1K – $15KAug 18
  • BIIBKevin Hern Traditional IRA Biogen Inc. - Common Stock (BIIB)Sell$1K – $15KAug 18
  • BABoeing Company (BA)Sell$1K – $15KAug 13
  • BABoeing Company (BA)Sell$15K – $50KAug 13
  • CANADIAN CNTY OKLA EDL FACS AUTH EDL 3.00000% 09/01/2029Buy$100K – $250KAug 24
  • CARRCarrier Global Corporation Common Stock (CARR)Sell$1K – $15KAug 14
+ 21 more trades in this filing
Made public 27 days after the earliest trade

Hern sold across 28 equity positions in August, from Adobe and Boeing to Microsoft and Home Depot, and put $100K to $250K into an Oklahoma municipal bond instead. That is a wholesale rotation out of stocks and into tax-free paper by a Ways and Means member now running for Senate, disclosed 27 days later.

BIIB Coverage